Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

With incoming president Donald Trump threatening a trade war with China, experts told BioSpace that the new administration ...

(Yicai) Jan. 3 -- US pharmaceutical company Gilead Sciences has been given the greenlight by Chinese regulators to sell its ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Gilead abandoned testing of the antibody in ... the drug is still in clinical development in China. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar ...

Gilead has won another victory in a wide-ranging ... fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest market, wiping around $14 billion off its ...